Top Markets
Coin of the day
Genetron Holdings Limited Genetron Holdings Limited

Genetron Holdings Limited

GTH
Κατάταξη σε μετοχές #15212
Genetron Holdings Limited (GTH) is a precision oncology company that... Genetron Holdings Limited (GTH) is a precision oncology company that specializes in cancer molecular profiling, utilizing advanced molecular biology and data science to enhance cancer treatment. The company delivers a range of services, including diagnosis, monitoring, and early screening, primarily through its proprietary laboratory-developed tests. Its product offerings encompass a variety of in-vitro diagnostic (IVD) solutions. These include the 8-gene lung cancer assay, an IVD product for lung cancer detection; the Genetron 3D biochip reading instrument; and the Genetron S5, a semiconductor-based next-generation sequencing (NGS) system that identifies nucleotides by detecting pH changes. Other key products are the Genetron Chef System, the production-scale Genetron S2000 sequencing platform, and Onco PanScan, a genomic profiling service for diverse solid tumors. Moreover, Genetron provides specialized assays such as the IDH1 and TERT gene assays for glioma, a fundamental thyroid assay for thyroid tumors, a platelet-derived growth factor receptor alpha assay for GIST cancer, and HCCscan, a qPCR-based assay designed to detect hepatocellular carcinoma. Beyond its direct services and products, the company offers genomics research and clinical development services, often in collaboration with biopharmaceutical companies globally. Genetron has also established a strategic partnership with JD Health to develop holistic solutions for comprehensive cancer management. The company was founded in 2015 and has its headquarters in Beijing, People's Republic of China.
Τιμή μετοχής
$4.03
Τελευταίος συγχρονισμός: 2024-03-28
Κεφαλαιοποίηση
$366.11M
Αλλαγή (1 ημέρα)
0.25%
Αλλαγή (1 έτος)
0.00%
Χώρα
CN
Εμπόριο Genetron Holdings Limited (GTH)

Κατηγορία

Η τιμή GTH με την κεφαλαιοποίηση του Β
Genetron Holdings Limited Genetron Holdings Limited
GTH
$4.03
Κεφαλαιοποίηση αγοράς του Genetron Holdings Limited(GTH)
Κεφαλαιοποίηση: $366.11M
Μέχρι το September 2026, η Genetron Holdings Limited έχει χρηματιστηριακή αξία $366.11M. Αυτό καθιστά τη Genetron Holdings Limited την 15212th πιο πολύτιμη εταιρεία στον κόσμο βάσει της κεφαλαιοποίησης σύμφωνα με τα δεδομένα μας. Η χρηματιστηριακή κεφαλαιοποίηση είναι η συνολική αγοραία αξία των μετοχών μιας εισηγμένης εταιρείας και χρησιμοποιείται συνήθως για να προσδιοριστεί η αξία μιας εταιρείας.
Ιστορικό κεφαλαιοποίησης αγοράς της Genetron Holdings Limited από 2020 έως 2026
GTH σε σύγκριση με τα 5 πιο δημοφιλή stocks
Η τιμή για GTH Το περιουσιακό στοιχείο B Η κεφαλαιοποίηση αγοράς του B Αποτελέσματα
Genetron Holdings Limited Genetron Holdings Limited
$58,635.34 $366.11M
$5.327T +1,454,871.21%
Genetron Holdings Limited Genetron Holdings Limited
$51,128.96 $366.11M
$4.645T +1,268,608.59%
Genetron Holdings Limited Genetron Holdings Limited
$44,803.81 $366.11M
$4.070T +1,111,657.10%
Genetron Holdings Limited Genetron Holdings Limited
$41,659.16 $366.11M
$3.785T +1,033,625.99%
Genetron Holdings Limited Genetron Holdings Limited
$30,712.57 $366.11M
$2.790T +761,998.39%